Background/Aims: Public understanding of the role of genetics in disease risk is key to appropriate disease prevention and detection. This study assessed the current extent of awareness and use of genetic testing in the US population. Additionally, the study identified characteristics of subgroups more likely to be at risk for low genetic literacy. Methods: The study used data from the National Cancer Institute’s 2017 Health Information National Trends Survey, including measures of genetic testing awareness, genetic testing applications and genetic testing usage. Multivariable logistic regression models estimated associations between sociodemographics, genetic testing awareness, and genetic testing use. Results: Fifty-seven percent of respondents were aware of genetic tests. Testing awareness differed by age, household income, and race/ethnicity. Most participants had heard of using tests to determine personal disease risk (82.58%) or inherited disease risk in children (81.41%), but less were familiar with determining treatment (38.29%) or drug efficacy (40.76%). Among those with genetic testing awareness, actual testing uptake was low. Conclusions: A large portion of the general public lacks genetic testing awareness and may benefit from educational campaigns. As precision medicine expands, increasing public awareness about genetic testing applications for disease prevention and treatment will be important to support population health.

Keywords:
Genetic literacy, Genetic education, Awareness, Knowledge, Knowledge gap, Population survey, Genetic testing, Health information, Health communication
1.
Hurle B, Citrin T, Jenkins JF, Kaphingst KA, Lamb N, Roseman JE, Bonham VL: What does it mean to be genomically literate? National Human Genome Research Institute meeting report. Genet Med 2013; 15: 658–663.
2.
Khoury MJ, Bowen MS, Burke W, Coates RJ, Dowling NF, Evans JP, Reyes M, St. Pierre J: Current priorities for public health practice in addressing the role of human genomics in improving population health. Am J Prev Med 2011; 40: 486–493.
3.
McBride CM, Bowen D, Brody LC, Condit CM, Croyle RT, Gwinn M, Khoury MJ, Koehly LM, Korf BR, Marteau TM, McLeroy K, Patrick K, Valente TW: Future health applications of genomics: priorities for communication, behavioral, and social sciences. Am J Prev Med 2010; 38: 556–565.
4.
Hawgood S, Hook-Barnard IG, O’Brien TC, Yamamoto KR: Precision medicine: beyond the inflection point. Sci Transl Med 2015; 7: 1–3.
5.
Khoury MJ, Iademarco MF, Riley WT: Precision public health for the era of precision medicine. Am J Prev Med 2016; 50: 398–401.
6.
Collins FS, Varmus H: A new initiative on precision medicine. N Engl J Med 2015; 372: 793–795.
7.
National Institutes of Health: All of Us Research Program, 2017. Retrieved from https://allofus.nih.gov.
8.
Agurs-Collins, T, Ferrer R, Ottenbacher A, Waters EA, O’Connell ME, Hamilton JG: Public awareness of direct-to-consumer genetic tests: findings from the 2013 US Health Information National Trends Survey. J Cancer Educ 2015; 30: 799–807.
9.
Mai PL, Vadaparampil ST, Breen N, McNeel TS, Wideroff L, Graubard BI: Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys. Am J Prev Med 2014; 46: 440–448.
10.
Roberts MC, Taber JM, Klein WM: Engagement with genetic information and uptake of genetic testing: the role of trust and personal cancer history. J Cancer Educ 2017; 20: 1–8.
11.
Taber JM, Chang CQ, Lam TK, Gillanders EM, Hamilton JG, Schully SD: Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey. Public Health Genomics 2015; 18: 67–77.
12.
Viswanath K, Finnegan JR: The knowledge gap hypothesis: Twenty-five years later; in B. Burleson (ed): Communication Yearb, Thousand Oaks, CA, Sage Publications, 1996, vol 19, pp 187–227.
13.
Goddard KA, Duquette D, Zlot A, Johnson J, Annis-Emeott A, Lee PW, Bland MP, Edwards KL, Oehlke K, Giles RT, Rafferty A, Cook ML, Khoury MJ: Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health 2009; 99: 442–445.
14.
Gammon, AD, Rothwell E, Simmons R, Lowery JT, Ballinger L, Hill DA, Boucher KM, Kinney A: Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer. J Genet Couns 2011; 20: 625–638.
15.
Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD: Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 2014; 17: 467–475.
16.
Lewis KL, Han PK, Hooker GW, Klein WM, Biesecker LG, Biesecker BB: Characterizing participants in the ClinSeq genome sequencing cohort as early adopters of a new health technology. PLoS One 2015; 10:e0132690.
17.
Finney Rutten LJ, David T, Beckjord EB, Blake K, Moser RP, Hesse BW: Picking up the pace: changes in method and frame for the Health Information National Trends Survey (2011–2014). J Health Comm 2012; 17: 979–989.
18.
Christensen FS, Jayaratne TE, Robets JS, Kardia SL, Petty EM: Understandings of basic genetics in the United States: results from a national survey of black and white men and women. Public Health Genomics 2010; 13: 467–476.
19.
Haga SB, Barry WT, Mills R, Ginsburg GS, Svetkey L, Sullivan J, Willard HF: Public knowledge of and attitudes toward genetics and genetic testing. Genet Test Mol Biomarkers 2013; 17: 327–335.
20.
Kaphingst KA, Blanchard M, Milam L, Pokharel M, Elrick A, Goodman M: Relationships between health literacy and genomics-related knowledge, self-efficacy, perceived importance, and communication in a medically underserved population. J Health Comm 2016; 21: 58–68.
21.
Ashida S, Goodman M, Pandya C, Koehly LM, Lachance C, Stafford J, Kaphingst KA: Age differences in genetic knowledge, health literacy, and causal beliefs for health conditions. Public Health Genomics 2011; 14: 307–316.
22.
Kusnoor SV, Koonce TY, Levy MA, Lovly CM, Naylor HM, Anderson IA: My cancer genome: evaluating an educational model to introduce patients and caregivers to precision medicine information. AMIA Jt Summits Transl Sci Proc 2016: 112–121.
23.
Lea DH, Kaphingst KA, Bowen D, Lipkus I, Hadley DW: Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics 2011; 14: 279–289.
24.
Abrams L, Koehly LM, Hooker GW, Paquin RS, Capella JN, McBride CM: Media exposure and genetic literacy skills to evaluate Angelina Jolie’s decision for prophylactic mastectomy. Public Health Genomics 2016; 19: 282–289.
This is a work of the US Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. Published by S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.